NZ182837A - Glucosamine derivatives and pharmaceutical compositions - Google Patents

Glucosamine derivatives and pharmaceutical compositions

Info

Publication number
NZ182837A
NZ182837A NZ182837A NZ18283776A NZ182837A NZ 182837 A NZ182837 A NZ 182837A NZ 182837 A NZ182837 A NZ 182837A NZ 18283776 A NZ18283776 A NZ 18283776A NZ 182837 A NZ182837 A NZ 182837A
Authority
NZ
New Zealand
Prior art keywords
pharmaceutical compositions
glucosamine derivatives
glucosamine
derivatives
pharmaceutical
Prior art date
Application number
NZ182837A
Other languages
English (en)
Inventor
A Sele
A Hartmann
G Baschang
J Stanek
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NZ182837A publication Critical patent/NZ182837A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ182837A 1975-12-10 1976-12-09 Glucosamine derivatives and pharmaceutical compositions NZ182837A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1604275A CH613709A5 (en) 1975-12-10 1975-12-10 Process for the preparation of glucosamine derivatives

Publications (1)

Publication Number Publication Date
NZ182837A true NZ182837A (en) 1978-07-28

Family

ID=4414012

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ182837A NZ182837A (en) 1975-12-10 1976-12-09 Glucosamine derivatives and pharmaceutical compositions

Country Status (30)

Country Link
JP (1) JPS5273820A (sv)
AR (2) AR224091A1 (sv)
AT (1) AT365607B (sv)
AU (1) AU508764B2 (sv)
BE (1) BE849214A (sv)
CA (1) CA1262400A (sv)
CH (2) CH613709A5 (sv)
CS (4) CS205025B2 (sv)
DD (1) DD129781A5 (sv)
DE (1) DE2655500A1 (sv)
DK (1) DK154654C (sv)
ES (2) ES454118A1 (sv)
FI (1) FI64164C (sv)
FR (1) FR2361902A1 (sv)
GB (1) GB1570625A (sv)
GR (1) GR61647B (sv)
HK (1) HK32883A (sv)
HU (1) HU177970B (sv)
IE (1) IE44190B1 (sv)
IL (1) IL51076A (sv)
MY (1) MY8400123A (sv)
NL (1) NL7613666A (sv)
NO (1) NO144850C (sv)
NZ (1) NZ182837A (sv)
PL (4) PL110794B1 (sv)
PT (1) PT65946B (sv)
SE (1) SE445923B (sv)
SG (1) SG11083G (sv)
SU (3) SU660589A3 (sv)
ZA (1) ZA767333B (sv)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
US4370265A (en) * 1974-10-22 1983-01-25 Agence Nationale De Valorisation Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
GB1571133A (en) * 1976-04-26 1980-07-09 Syntex Inc Immuniological adjuvant peptidoglycans compounds and methods of preparation thereof
EP0002677B1 (en) 1977-12-02 1982-10-13 Takeda Chemical Industries, Ltd. Glucosamine-peptide derivatives and their pharmaceutical compositions
EP0003833B2 (de) * 1978-02-24 1990-12-19 Ciba-Geigy Ag Antigenderivate, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
FR2420545A1 (fr) * 1978-03-20 1979-10-19 Anvar Nouveaux esters de l'acide n-acetyl-muramyl-aminoacyl-glutamique ou des derives de substitution de celui-ci a proprietes anti-infectieuses et/ou d'adjuvants immunologiques
FR2442241A2 (fr) * 1978-03-20 1980-06-20 Anvar Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes
FR2428051A1 (fr) * 1978-06-05 1980-01-04 Anvar Nouveaux composes du type muramyl-peptide et medicaments les contenant
FR2428050A1 (fr) * 1978-06-05 1980-01-04 Anvar Oligomeres de composes du type muramyl-peptide et medicaments les contenant
FR2446292A1 (fr) * 1979-01-12 1980-08-08 Anvar Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant
US4256735A (en) 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
FR2449697A1 (fr) 1979-02-20 1980-09-19 Anvar Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
FI75578C (sv) * 1979-07-25 1988-07-11 Ciba Geigy Ag Analogiförfarande för framställning av farmakologiskt verkande lipofil a fosfatidylmuramylpeptider.
JPS5649396A (en) * 1979-09-28 1981-05-02 Dai Ichi Seiyaku Co Ltd Novel muramyldipeptide derivative
EP0026746B1 (de) * 1979-10-02 1985-04-10 Ciba-Geigy Ag Kombinationspräparate zur Anwendung in einem Verfahren zur Steigerung der Wirkung von Antibiotika, antibiotische Präparate mit gesteigerter Wirksamkeit und Verfahren zu deren Herstellung
FI803077A (fi) 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider
US4409209A (en) * 1979-10-12 1983-10-11 Ciba-Geigy Corporation Novel phosphorylmuramyl peptides and processes for the manufacture thereof
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
US4310514A (en) 1980-05-05 1982-01-12 Merck & Co., Inc. Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
EP0056560A1 (de) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Antibiotische Präparate mit gesteigerter Wirksamkeit, Verfahren zu deren Herstellung und Verfahren zur Steigerung der antibiotischen Wirkung von Antibiotika
GR78246B (sv) * 1981-01-23 1984-09-26 Ciba Geigy Ag
JPS6042398A (ja) * 1983-08-18 1985-03-06 Toshiyuki Hamaoka ムラミルジペプチド活性エステル誘導体
EP0541486A1 (de) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclische Konjugate
WO2006118327A1 (ja) * 2005-04-27 2006-11-09 Oxygenix Co Ltd カチオン性アミノ酸型脂質
WO2016138286A1 (en) 2015-02-26 2016-09-01 Stc.Unm Irgm and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
US10927147B2 (en) 2015-12-10 2021-02-23 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
CN108883080B (zh) * 2015-12-15 2021-12-21 巴拉特生物技术国际有限公司 胞壁酰肽衍生物化合物、其合成及其用途
MX2020002010A (es) 2017-08-21 2020-07-13 Celgene Corp Procesos para la preparacion de 4,5-diamino-5-oxopentanoato de (s)-terc-butilo.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents

Also Published As

Publication number Publication date
AR220686A1 (es) 1980-11-28
PT65946A (en) 1977-01-01
AT365607B (de) 1982-02-10
PT65946B (en) 1978-06-14
HU177970B (en) 1982-02-28
NO144850B (no) 1981-08-17
AU508764B2 (en) 1980-04-03
CS205025B2 (en) 1981-04-30
NO144850C (no) 1981-11-25
DD129781A5 (de) 1978-02-08
SE445923B (sv) 1986-07-28
SE7613851L (sv) 1977-06-11
SG11083G (en) 1983-09-16
CS205027B2 (en) 1981-04-30
PL194291A1 (pl) 1978-10-23
BE849214A (fr) 1977-06-09
PL110353B1 (en) 1980-07-31
HK32883A (en) 1983-09-02
PL110787B1 (en) 1980-07-31
CH613709A5 (en) 1979-10-15
IE44190L (en) 1977-06-10
ES465514A1 (es) 1978-09-16
NL7613666A (nl) 1977-06-14
DK154654B (da) 1988-12-05
JPS638118B2 (sv) 1988-02-19
AR224091A1 (es) 1981-10-30
SU660589A3 (ru) 1979-04-30
IL51076A0 (en) 1977-02-28
CA1262400A (en) 1989-10-17
MY8400123A (en) 1984-12-31
DK552476A (da) 1977-06-11
IL51076A (en) 1980-09-16
ES454118A1 (es) 1978-03-01
FR2361902A1 (fr) 1978-03-17
FI64164C (fi) 1983-10-10
DE2655500A1 (de) 1977-06-23
PL112672B1 (en) 1980-10-31
ZA767333B (en) 1977-11-30
DK154654C (da) 1989-05-08
NO764191L (sv) 1977-06-13
FI763541A (sv) 1977-06-11
PL110794B1 (en) 1980-07-31
SU747430A3 (ru) 1980-07-23
GB1570625A (en) 1980-07-02
GR61647B (en) 1978-12-05
CS205028B2 (en) 1981-04-30
FR2361902B1 (sv) 1980-11-07
CH614718A5 (en) 1979-12-14
ATA909276A (de) 1981-06-15
FI64164B (fi) 1983-06-30
DE2655500C2 (sv) 1988-12-22
CS205026B2 (en) 1981-04-30
IE44190B1 (en) 1981-09-09
AU2042276A (en) 1978-06-15
SU1060118A3 (ru) 1983-12-07
JPS5273820A (en) 1977-06-21

Similar Documents

Publication Publication Date Title
NZ182837A (en) Glucosamine derivatives and pharmaceutical compositions
NZ181444A (en) -phenyl benzylidene derivatives and pharmaceutical compositions
NZ180529A (en) Erythromyc-9-yl-amine derivatives and pharmaceutical compositions
NZ181726A (en) Pyrrolidine derivatives and pharmaceutical compositions
NZ183150A (en) 7-aminothiazolyl-iminoa-cetamido-cephalosporin derivatives and pharmaceutical compositions
NZ179835A (en) Aminoalkynoic acids,derivatives and pharmaceutical compositions
NZ181959A (en) Pyrimidine derivatives and pharmaceutical compositions
NZ182759A (en) Pyrimidine derivatives and pharmaceutical compositions
ZA763917B (en) Pharmaceutical compositions and compounds
NZ182665A (en) Amine derivatives and pharmaceutical compositions
NZ181009A (en) Heteroaryl derivatives and pharmaceutical compositions
GB1518041A (en) Oxadiazolinone derivatives and compositions containing them
GB1537880A (en) 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them
NZ184755A (en) 2-benzylpyrrolidine derivatives and pharmaceutical compositions
NZ182591A (en) 14-substituted-daunorubicins and pharmaceutical compositions
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
NZ182161A (en) Alkoxy-pyridine-carobxamide derivatives and pharmaceutical compositions
NZ182581A (en) -amino-ketones and pharmaceutical compositions
NZ181864A (en) Noroxymorphones and pharmaceutical compositions
NZ181972A (en) N-aryl-n-(4-piperidyl)-arylacetamide derivatives and pharmaceutical compositions
NZ185642A (en) Morphanthridine derivatives and pharmaceutical compositions
NZ180535A (en) Erythromicin derivatives and pharmaceutical compositions
NZ184103A (en) Fenzodioxole derivatives and pharmaceutical compositions
NZ181168A (en) 3-sulphamyl benzylamine derivatives and pharmaceutical compositions intermidiates
NZ181727A (en) Pyrroline-2-one derivatives and pharmaceutical compositions